Virtu Financial’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12,641
Closed -$1.85M 2051
2019
Q1
$1.85M Buy
+12,641
New +$1.83M 0.1% 150
2018
Q1
Sell
-7,673
Closed -$1.25M 2920
2017
Q4
$1.25M Sell
7,673
-20,478
-73% -$3.67M 0.07% 348
2017
Q3
$5.77M Buy
+28,151
New +$6.55M 0.29% 33
2017
Q1
Sell
-3,773
Closed -$792K 615
2016
Q4
$792K Buy
+3,773
New +$782K 0.08% 182
2016
Q1
Sell
-1,430
Closed -$447K 551
2015
Q4
$447K Buy
+1,430
New +$426K 0.06% 246

Other funds holding AGN

Virtu Financial's AGN Position: Q2 2019 in Review

Virtu Financial sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 12,641 shares — an estimated $1.85M sold.

Virtu Financial first reported a position in AGN in Q4 2015 and held it in 5 quarters. The position peaked at $5.77M in Q3 2017. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Virtu Financial reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Virtu Financial sold 12,641 Allergan plc shares in Q2 2019, an estimated $1.85M.
  • Virtu Financial first reported a position in Allergan plc in Q4 2015 and held it in 5 quarters.
  • Virtu Financial's Allergan plc position peaked at $5.77M in Q3 2017.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Virtu Financial's 13F filing for Q2 2019, filed 13 Aug 2019.